Commentary: Transmeta: This Ipo Darling May Be A HeartbreakerBy
For an initial public offering market in deep freeze, the Nov. 7 debut of chipmaker Transmeta Corp. came like a balmy autumn day. It was the most highly anticipated IPO of the season--and it didn't disappoint. After nearly doubling its offering price to $21 in the days preceding liftoff, Transmeta soared another 115% on its first day of public trading, giving the startup a heady market capitalization of nearly $5.8 billion.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.